1. Chain length of dietary fatty acids determines gastrointestinal motility and visceromotor function in mice in a fatty acid binding protein 4-dependent manner
   Paula Mosińska et al, 2020, European Journal of Nutrition CrossRef
2. The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
   Tarek Mazzawi et al, 2021, Frontiers in Cellular and Infection Microbiology CrossRef
3. Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome
   TAREK MAZZAWI et al, 2014, Molecular Medicine Reports CrossRef
4. Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance
   TAREK MAZZAWI et al, 2016, International Journal of Molecular Medicine CrossRef
5. Possible role of intestinal stem cells in the pathophysiology of irritable bowel syndrome
   Magdy El-Salhy, 2020, World Journal of Gastroenterology CrossRef
6. Increased Chromogranin A Cell Density in the Large Intestine of Patients with Irritable Bowel Syndrome after Receiving Dietary Guidance
   Tarek Mazzawi et al, 2015, Gastroenterology Research and Practice CrossRef
7. A Starch- and Sucrose-Reduced Diet in Irritable Bowel Syndrome Leads to Lower Circulating Levels of PAI-1 and Visfatin: A Randomized Controlled Study
   Bodil Roth et al, 2022, Nutrients CrossRef
8. Biomolecules from Plant Wastes Potentially Relevant in the Management of Irritable Bowel Syndrome and Co-Occurring Symptomatology
   Ioana-Miruna Balmus et al, 2022, Molecules CrossRef
9. Interaction between diet and gastrointestinal endocrine cells
   MAGDY EL-SALHY et al, 2016, Biomedical Reports CrossRef
10. A carbohydrate-restricted diet for patients with irritable bowel syndrome lowers serum C-peptide, insulin, and leptin without any correlation with symptom reduction
    Khadija Saidi et al, 2021, Nutrition Research CrossRef
11. From Food Map to FODMAP in Irritable Bowel Syndrome
    Pasquale Mansueto et al, 2016, Human Nutrition from the Gastroenterologist’s Perspective CrossRef
12. Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities
    Magdy El-Salhy, 2015, World Journal of Gastroenterology CrossRef
13. Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review)
    Tarek Mazzawi et al, 2017, International Journal of Molecular Medicine CrossRef
14. Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance
    Tarek Mazzawi et al, 2017, Experimental Biology and Medicine CrossRef
15. Pilotstudie: Einfluss einer FODMAP-armen Diät auf das Mikrobiom des menschlichen Darms bei Reizdarmsyndrom
    Christina Reiner et al, 2017, Journal für Gastroenterologische und Hepatologische Erkrankungen CrossRef
16. Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome
    Tarek Mazzawi et al, 2016, Experimental and Therapeutic Medicine CrossRef
17. FOD What? A Low FODMAP Experience
    Julia A. Carlson et al, 2015, Nutrition Today CrossRef
18. Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones
    Magdy El-Salhy et al, 2019, Nutrients CrossRef
19. Irritable bowel syndrome and small intestinal bacterial overgrowth: Assessment with breath test
    LA Costa et al, 2020, Archives of Clinical Gastroenterology CrossRef
20. Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome
    T Mazzawi et al, 2016, European Journal of Clinical Nutrition CrossRef
21. Underlying molecular and cellular mechanisms in childhood irritable bowel syndrome
    Bruno P. Chumpitazi et al, 2016, Molecular and Cellular Pediatrics CrossRef
22. Long‐term impact of the low‐FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome
    M. O'Keeffe et al, 2018, Neurogastroenterology & Motility CrossRef
23. Recent developments in the pathophysiology of irritable bowel syndrome
    Magdy El-Salhy, 2015, World Journal of Gastroenterology CrossRef
24. Changes in colonic enteroendocrine cells of patients with irritable bowel syndrome following fecal microbiota transplantation
    Tarek Mazzawi et al, 2022, Scandinavian Journal of Gastroenterology CrossRef
25. Theories behind the effect of starch‑ and sucrose‑reduced diets on gastrointestinal symptoms in irritable bowel syndrome (Review)
    Bodil Ohlsson, 2021, Molecular Medicine Reports CrossRef
26. Diet in irritable bowel syndrome
    Magdy El-Salhy et al, 2015, Nutrition Journal CrossRef
27. Role of FODMAPs in Patients With Irritable Bowel Syndrome
    Pasquale Mansueto et al, 2015, Nutrition in Clinical Practice CrossRef
28. Stem Cells in the Intestine: Possible Roles in Pathogenesis of Irritable Bowel Syndrome
    Sutheera Ratanasirintrawoot et al, 2016, Journal of Neurogastroenterology and Motility CrossRef